Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Modeling of implementation of the new Organ Procurement and Transplantation Network/United Network for Organ Sharing policy for patients with hepatocellular carcinoma.

Kokabi N, Nezami N, Xing M, Ludwig JM, Strazzabosco M, Kim HS.

J Comp Eff Res. 2019 Sep 12. doi: 10.2217/cer-2019-0076. [Epub ahead of print]

PMID:
31512955
2.

The impact of socioeconomic status on outcomes in hepatocellular carcinoma: Inferences from primary insurance.

Sellers CM, Uhlig J, Ludwig JM, Taddei T, Stein SM, Lim JK, Kim HS.

Cancer Med. 2019 Aug 22. doi: 10.1002/cam4.2251. [Epub ahead of print]

3.

Inflammatory markers in intrahepatic cholangiocarcinoma: Effects of advanced liver disease.

Sellers CM, Uhlig J, Ludwig JM, Stein SM, Kim HS.

Cancer Med. 2019 Aug 20. doi: 10.1002/cam4.2373. [Epub ahead of print]

4.

Pneumodissection Prior to Percutaneous Cryoablation of a Small Renal Tumor.

Spieker N, Ludwig JM, Theysohn J, Schaarschmidt B.

Rofo. 2019 Jul 4. doi: 10.1055/a-0929-7476. [Epub ahead of print] No abstract available.

PMID:
31272107
5.

Cryotherapy for nodal metastasis in NSCLC with acquired resistance to immunotherapy.

Adam LC, Raja J, Ludwig JM, Adeniran A, Gettinger SN, Kim HS.

J Immunother Cancer. 2018 Dec 12;6(1):147. doi: 10.1186/s40425-018-0468-x.

6.

Oncolytic virus immunotherapy: future prospects for oncology.

Raja J, Ludwig JM, Gettinger SN, Schalper KA, Kim HS.

J Immunother Cancer. 2018 Dec 4;6(1):140. doi: 10.1186/s40425-018-0458-z. Review.

7.

Imaging of the intrahepatic portal vein in children with extrahepatic portal vein thrombosis - Comparison of magnetic resonance imaging and retrograde portography.

Kathemann S, Lainka E, Ludwig JM, Wetter A, Paul A, Hoyer PF, Forsting M, Schlosser T.

J Pediatr Surg. 2019 Aug;54(8):1686-1690. doi: 10.1016/j.jpedsurg.2018.10.049. Epub 2018 Oct 30.

PMID:
30497819
8.

Diverse Lineages of Candida albicans Live on Old Oaks.

Bensasson D, Dicks J, Ludwig JM, Bond CJ, Elliston A, Roberts IN, James SA.

Genetics. 2019 Jan;211(1):277-288. doi: 10.1534/genetics.118.301482. Epub 2018 Nov 21.

9.

Survival Rates after Thermal Ablation versus Stereotactic Radiation Therapy for Stage 1 Non-Small Cell Lung Cancer: A National Cancer Database Study.

Uhlig J, Ludwig JM, Goldberg SB, Chiang A, Blasberg JD, Kim HS.

Radiology. 2018 Dec;289(3):862-870. doi: 10.1148/radiol.2018180979. Epub 2018 Sep 18.

PMID:
30226453
10.

Genomic mutations and histopathologic biomarkers in Y90 radioembolization for chemorefractory colorectal liver metastases.

Dendy MS, Ludwig JM, Kokabi N, Stein SM, Lacy J, Hochster HS, Kim HS.

Oncotarget. 2018 Aug 21;9(65):32523-32533. doi: 10.18632/oncotarget.25992. eCollection 2018 Aug 21.

11.

Anti-inflammatory properties of ursodeoxycholyl lysophosphatidylethanolamide in endotoxin-mediated inflammatory liver injury.

Ludwig JM, Zhang Y, Chamulitrat W, Stremmel W, Pathil A.

PLoS One. 2018 May 24;13(5):e0197836. doi: 10.1371/journal.pone.0197836. eCollection 2018.

12.
13.

Using Appendicitis to Improve Estimates of Childhood Medicaid Participation Rates.

Silber JH, Zeigler AE, Reiter JG, Hochman LL, Ludwig JM, Wang W, Calhoun SR, Pati S.

Acad Pediatr. 2018 Jul;18(5):593-600. doi: 10.1016/j.acap.2018.03.008. Epub 2018 Mar 23.

PMID:
29581042
14.

Immuno-thermal ablations - boosting the anticancer immune response.

Slovak R, Ludwig JM, Gettinger SN, Herbst RS, Kim HS.

J Immunother Cancer. 2017 Oct 17;5(1):78. doi: 10.1186/s40425-017-0284-8. Review.

15.

Infiltrative Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis Treated With a Single High-Dose Y90 Radioembolization and Subsequent Liver Transplantation Without a Recurrence.

Dendy MS, Camacho JC, Ludwig JM, Krasinskas AM, Knechtle SJ, Kim HS.

Transplant Direct. 2017 Aug 18;3(9):e206. doi: 10.1097/TXD.0000000000000707. eCollection 2017 Sep.

16.

Radiofrequency ablation versus resection for hepatocellular carcinoma in patients with Child-Pugh A liver cirrhosis: a meta-analysis.

Jia JB, Zhang D, Ludwig JM, Kim HS.

Clin Radiol. 2017 Dec;72(12):1066-1075. doi: 10.1016/j.crad.2017.07.024. Epub 2017 Aug 26.

PMID:
28851491
17.

Hepatic intra-arterial injection of irinotecan drug eluting beads (DEBIRI) for patients with unresectable colorectal liver metastases: A systematic review.

Akinwande O, Dendy M, Ludwig JM, Kim HS.

Surg Oncol. 2017 Sep;26(3):268-275. doi: 10.1016/j.suronc.2017.05.003. Epub 2017 May 22. Review.

PMID:
28807246
18.

Targeted Yttrium 89-Doxorubicin Drug-Eluting Bead-A Safety and Feasibility Pilot Study in a Rabbit Liver Cancer Model.

Ludwig JM, Xing M, Gai Y, Sun L, Zeng D, Kim HS.

Mol Pharm. 2017 Aug 7;14(8):2824-2830. doi: 10.1021/acs.molpharmaceut.7b00336. Epub 2017 Jul 25.

19.
20.

Establishment of human metastatic colorectal cancer model in rabbit liver: A pilot study.

Prieto V, Ludwig JM, Farris AB, Nagaraju GP, Lawal TO, El-Rayes B, Kim HS.

PLoS One. 2017 May 5;12(5):e0177212. doi: 10.1371/journal.pone.0177212. eCollection 2017.

21.

Predictors and prognosticators for survival with Yttrium-90 radioembolization therapy for unresectable colorectal cancer liver metastasis.

Dendy MS, Ludwig JM, Kim HS.

Oncotarget. 2017 Jun 6;8(23):37912-37922. doi: 10.18632/oncotarget.16007. Review.

22.

In vitro biologic efficacy of sunitinib drug-eluting beads on human colorectal and hepatocellular carcinoma-A pilot study.

Lahti S, Ludwig JM, Xing M, Sun L, Zeng D, Kim HS.

PLoS One. 2017 Apr 6;12(4):e0174539. doi: 10.1371/journal.pone.0174539. eCollection 2017.

23.

Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus 90Y-radioembolization for hepatocellular carcinoma.

Ludwig JM, Zhang D, Xing M, Kim HS.

Eur Radiol. 2017 May;27(5):2031-2041. doi: 10.1007/s00330-016-4548-3. Epub 2016 Aug 25.

PMID:
27562480
24.

Auditing Practice Style Variation in Pediatric Inpatient Asthma Care.

Silber JH, Rosenbaum PR, Wang W, Ludwig JM, Calhoun S, Guevara JP, Zorc JJ, Zeigler A, Even-Shoshan O.

JAMA Pediatr. 2016 Sep 1;170(9):878-86. doi: 10.1001/jamapediatrics.2016.0911.

PMID:
27398908
25.

Reply to: "Percutaneous Management of Benign Biliary Strictures: Is It Time to Focus on Reducing Procedure Invasiveness?".

Ludwig JM, Knechtle SJ, Kim HS.

J Vasc Interv Radiol. 2016 Jun;27(6):936-7. doi: 10.1016/j.jvir.2016.03.003. Epub 2016 Jun 3. No abstract available.

PMID:
27287980
26.

SW43-DOX ± loading onto drug-eluting bead, a potential new targeted drug delivery platform for systemic and locoregional cancer treatment - An in vitro evaluation.

Ludwig JM, Gai Y, Sun L, Xiang G, Zeng D, Kim HS.

Mol Oncol. 2016 Aug;10(7):1133-45. doi: 10.1016/j.molonc.2016.05.003. Epub 2016 May 21.

27.

Lung Shunt Fraction prior to Yttrium-90 Radioembolization Predicts Survival in Patients with Neuroendocrine Liver Metastases: Single-Center Prospective Analysis.

Ludwig JM, Ambinder EM, Ghodadra A, Xing M, Prajapati HJ, Kim HS.

Cardiovasc Intervent Radiol. 2016 Jul;39(7):1007-14. doi: 10.1007/s00270-016-1323-4. Epub 2016 Mar 10.

PMID:
26964779
28.

Survival in unresectable AJCC stage I and II HCC and the effect of DEB-TACE: SEER versus tertiary cancer center cohort study.

Xing M, Kokabi N, Prajapati HJ, Close O, Ludwig JM, Kim HS.

J Comp Eff Res. 2016 Mar;5(2):141-54. doi: 10.2217/cer.15.54. Epub 2016 Mar 7.

PMID:
26946950
29.

Indirect Standardization Matching: Assessing Specific Advantage and Risk Synergy.

Silber JH, Rosenbaum PR, Ross RN, Ludwig JM, Wang W, Niknam BA, Hill AS, Even-Shoshan O, Kelz RR, Fleisher LA.

Health Serv Res. 2016 Dec;51(6):2330-2357. doi: 10.1111/1475-6773.12470. Epub 2016 Feb 29.

30.

The Role of Diffusion-Weighted Imaging (DWI) in Locoregional Therapy Outcome Prediction and Response Assessment for Hepatocellular Carcinoma (HCC): The New Era of Functional Imaging Biomarkers.

Ludwig JM, Camacho JC, Kokabi N, Xing M, Kim HS.

Diagnostics (Basel). 2015 Nov 30;5(4):546-63. doi: 10.3390/diagnostics5040546. Review.

31.

Comparison of the Value of Nursing Work Environments in Hospitals Across Different Levels of Patient Risk.

Silber JH, Rosenbaum PR, McHugh MD, Ludwig JM, Smith HL, Niknam BA, Even-Shoshan O, Fleisher LA, Kelz RR, Aiken LH.

JAMA Surg. 2016 Jun 1;151(6):527-36. doi: 10.1001/jamasurg.2015.4908.

32.

Percutaneous Management of Benign Biliary Strictures with Large-Bore Catheters: Comparison between Patients with and without Orthotopic Liver Transplantation.

Ludwig JM, Webber GR, Knechtle SJ, Spivey JR, Xing M, Kim HS.

J Vasc Interv Radiol. 2016 Feb;27(2):219-225.e1. doi: 10.1016/j.jvir.2015.10.021. Epub 2015 Dec 17.

PMID:
26710970
33.
34.

Examining Causes of Racial Disparities in General Surgical Mortality: Hospital Quality Versus Patient Risk.

Silber JH, Rosenbaum PR, Kelz RR, Gaskin DJ, Ludwig JM, Ross RN, Niknam BA, Hill A, Wang M, Even-Shoshan O, Fleisher LA.

Med Care. 2015 Jul;53(7):619-29. doi: 10.1097/MLR.0000000000000377.

35.

Racial disparities in colon cancer survival: a matched cohort study.

Silber JH, Rosenbaum PR, Ross RN, Niknam BA, Ludwig JM, Wang W, Clark AS, Fox KR, Wang M, Even-Shoshan O, Giantonio BJ.

Ann Intern Med. 2014 Dec 16;161(12):845-54. doi: 10.7326/M14-0900.

PMID:
25506853
36.

A hospital-specific template for benchmarking its cost and quality.

Silber JH, Rosenbaum PR, Ross RN, Ludwig JM, Wang W, Niknam BA, Saynisch PA, Even-Shoshan O, Kelz RR, Fleisher LA.

Health Serv Res. 2014 Oct;49(5):1475-97. doi: 10.1111/1475-6773.12226. Epub 2014 Sep 8.

37.

Anesthesia technique, mortality, and length of stay after hip fracture surgery.

Neuman MD, Rosenbaum PR, Ludwig JM, Zubizarreta JR, Silber JH.

JAMA. 2014 Jun 25;311(24):2508-17. doi: 10.1001/jama.2014.6499.

38.

Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF-β1/Smad2/3 signalling.

Pathil A, Mueller J, Ludwig JM, Wang J, Warth A, Chamulitrat W, Stremmel W.

Br J Pharmacol. 2014 Nov;171(22):5113-26. doi: 10.1111/bph.12837. Epub 2014 Sep 5.

39.

Template matching for auditing hospital cost and quality.

Silber JH, Rosenbaum PR, Ross RN, Ludwig JM, Wang W, Niknam BA, Mukherjee N, Saynisch PA, Even-Shoshan O, Kelz RR, Fleisher LA.

Health Serv Res. 2014 Oct;49(5):1446-74. doi: 10.1111/1475-6773.12156. Epub 2014 Mar 3.

40.

Characteristics associated with differences in survival among black and white women with breast cancer.

Silber JH, Rosenbaum PR, Clark AS, Giantonio BJ, Ross RN, Teng Y, Wang M, Niknam BA, Ludwig JM, Wang W, Even-Shoshan O, Fox KR.

JAMA. 2013 Jul 24;310(4):389-97. doi: 10.1001/jama.2013.8272.

PMID:
23917289
41.

Racial disparities in operative procedure time: the influence of obesity.

Silber JH, Rosenbaum PR, Ross RN, Even-Shoshan O, Kelz RR, Neuman MD, Reinke CE, Ludwig JM, Kyle FA, Bratzler DW, Fleisher LA.

Anesthesiology. 2013 Jul;119(1):43-51. doi: 10.1097/ALN.0b013e31829101de.

42.

Comparative effectiveness of regional versus general anesthesia for hip fracture surgery in adults.

Neuman MD, Silber JH, Elkassabany NM, Ludwig JM, Fleisher LA.

Anesthesiology. 2012 Jul;117(1):72-92. doi: 10.1097/ALN.0b013e3182545e7c.

PMID:
22713634
43.

A new surgical procedure for the correction of the incompetent cervix during pregnancy. The Wurm procedure.

HEFNER JD, PATOW WE, LUDWIG JM Jr.

Obstet Gynecol. 1961 Nov;18:616-20. No abstract available.

PMID:
13905932

Supplemental Content

Loading ...
Support Center